-
Diabetes and Obesity – WHO Updates Core Essential Medicines List, Charting a New Direction
Nov , 18 2025
Diabetes and obesity have emerged as two of the most urgent health challenges facing the world today. A staggering 800 million people were living with diabetes in 2022, with half remaining untreated. ...
read more
-
A Comprehensive Analysis: Semaglutide API, R&D and Manufacturing in China
Dec , 23 2025
With the growing global focus on GLP-1 based therapies, China's role in this field has become increasingly pivotal. Core Concept: What is Semaglutide API? Semaglutide API (Semaglutide Active Ingredien...
read more